Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Delårsrapport 1 JANUARI – 30 SEPTEMBER 2022 FLOWSCAPE TECHNOLOGY AB (publ), ORG.Nr. 556725-4866

Styrelsen och verkställande direktören för Flowscape Technology AB avger härmed rapport för perioden januari – september 2022. Belopp anges i tusentals kronor. Siffror inom parentes avser motsvarande period föregående år This information is only available in Swedish.Januari – September i korthet, concern FÖRSTA NIO MÅNADERNA (JANUARI-SEPTEMBER) · Nettoomsättningen uppgick till 32 020(24 249) TSEK · Rörelseresultat före avskrivningar uppgick till 1 643(1 899) TSEK · Resultat efter finansiella poster uppgick till -14 553 (-15 858) TSEK · Inkomna ordrar uppgick till 20 385 (

Episurf to present commercial focus areas at today’s Capital Markets Day

At today's Capital Markets Day, Episurf Medical (NASDAQ: EPIS B) presents strategic focus areas, which includes geographic expansion into new markets including The United States, and new product introductions across multiple anatomic locations that address osteoarthritis. During the Capital Markets Day, CEO Pål Ryfors, members of the management team, and key customers will present and discuss a growth strategy concentrating on three primary aspects: · New customers – continued customer acquisition in existing markets · New markets – new areas of geographic expansion, including

Dignitana hires Johan Johansson to Head Operations, Research and Development

Dignitana  has named Johan Johansson as Vice President of Operations, Research and Development. He begins the role immediately at the Company’s headquarters in Lund.“Johan brings not only proven success in Operations, Research and Development, but also specific experience with devices for temperature management as well as side effects of chemotherapy. This expertise aligns well with our strategic goals and Johan is a valuable addition to our management team,” said Dignitana CEO Catarina Mård Löwenadler.  Most recently Johansson worked at Additude AB supporting

Arbetsförmedlingen and Bioservo help people return to work

People who suffer from impaired hand function often find it difficult to continue working, or to return to work after rehabilitation. The Swedish Public Employment Service, Arbetsförmedlingen, works actively with new technology to help people, an example is the grip-strengthening glove Carbonhand[®] from Bioservo.[Carbonhand som arbetshjlpmedel] Bioservo and Arbetsförmedlingen have collaborated for several years and helped people with impaired hand function to continue working or be able to start working again after undergoing rehabilitation. People who suffer from impaired hand function

Interim Report 1 January – 30 September 2022

· Continued strong growth in customer base, 48% growth year-on-year · Update on commercial focus areas to be presented at Capital Markets Day · Progress on all three US regulatory processes – closing in on important milestones”Following a very turbulent time during the pandemic, with significant volatility between the quarters, we have experienced a positive customer acquisition trend for several consecutive quarters. In the previous CEO statement, I clearly stated that this was a key priority now as we are not only coming out of the pandemic but also having a more commercial focus,

Elicera Therapeutics’ co-founders receive additional grants totalling 7,65 MSEK from the Swedish Cancer Society to support CAR T research

Gothenburg, November 16, 2022 - Elicera Therapeutics AB (publ) (“Elicera”), a clinical stage cell and gene therapy company developing next-generation therapies based on oncolytic viruses and CAR T-cells armed with the company’s proprietary and commercially available platform iTANK, today announced that co-founders Professor Magnus Essand and Associate Professor Di Yu have received a total of 7,65 MSEK in funding from the Swedish Cancer Society to support their CAR T research programmes in progress at Uppsala University.Elicera will not be a direct recipient of the funding. The outcomes of

MEKO launches a new user-friendly booking solution for car services in Northern Europe

MEKO launches a new digital booking system that makes it easier for the car owner to book car services. The booking system will be implemented in all MEKO workshop chains from 2023 to improve the customer journey and increase the number of digital bookings. The solution will be offered to other companies with car-related services that want to increase the number of digital bookings. – We noticed that car owners felt unsure of what service they should book for a given situation. In other industries, such as food or fashion, online shoppers can easily and intuitively find what they need.

SelectImmune Pharma Interim report Q1 2022/2023

SELECTIMMUNE PHARMA IN BRIEF • SelectImmune Pharma is an innovative biotech company that develops novel immunotherapies against infection. • Excessive innate immune responses to infection cause symptoms and pathology in acute pyelonephritis and acute cystitis. Immunomodulation is therefore a realistic option for treating these conditions as alternatives or complements to antibiotics. • Several of the company’s drug candidates have shown protective effects against bacterial infection in animal models, including acute cystitis, severe kidney infection and urosepsis. • One drug

Scandion Oncology – Interim Report Q3 2022

Scandion Oncology (Scandion) today announces its interim report for Q3 2022. The following is taken from the report. Johnny Stilou, Acting CEO & CFO, comments “In the third quarter of 2022 we managed to raise approximately 42 MDKK net in a very difficult stock market. The raised capital will take us well into 2024.” Key Figures & Highlights TDKK Q3 2022 Q1-Q3 2022 Q3 2021 Q1-Q3 2021 FY 2021 Operating -23,626 -64,778 -15,392 -40,788 -55,367loss Net finance -1,447 -1,735 -359 -1,606 -1,846income/

Crunchfish publishes interim report Q3 2022

Today, Crunchfish AB (“Crunchfish”) publishes the company’s interim report for the third quarter and first nine months of 2022. Below is a brief summary of the report.Group financials 2022-07-01   2021-07-01   2022-01-01   2021-01-01 2022-09-30   2021-09-30   2022-09-30   2021-09-30         Net sales (SEK)   5 805 573   1 055 973   6 156 359   3 073 760Profit or loss   -900 384   -7 293 098   -14 381 760   -23 688 767before tax (SEK)  Earnings per share   -0.03

Chief Executive Offier, Philipp Mathieu, buys Immunovia warrants

LUND (SWEDEN) – Immunovia AB (Nasdaq: IMMNOV) announces today that Philipp Mathieu, CEO of Immunovia, has purchased 150000 warrants of the 2022/2026 scheme for approximately 297 KSEK.  His total holding now amounts to 2108 shares and 250 000 warrants in Immunovia. The warrants have a subscription price per share of SEK 88.69. Other management team members have subscribed for 100 000 warrants of the same scheme.     For more information, please contact:Karin Almqvist Liwendahl CFOkain.almqvist.liwendahl@immunovia.com+46 70 911 56 08       About Immunovia

Medivir to present at the Redeye Life Science Day

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announces that the company will participate at the Redeye Life Science Day on November 24, 2022. CEO Jens Lindberg will participate in an interview that will be broadcasted live at Redeye’s web site at 13.40 CET. On the event page you will find a pre-recorded company presentation as well as a form where you can post questions directly to us.The interview is live broadcasted and can be followed at the event page;

KONE completes repurchase of own shares

KONE Corporation, stock exchange release, November 16, 2022 at 9.30 a.m. EET KONE completes repurchase of own shares KONE has completed the repurchase of the company’s own class B shares, which started on November 3, 2022 and ended on November 15, 2022. During this period, a total of 1,083,500 own shares were repurchased for an average price of EUR 46.1051 per share. The shares were repurchased in public trading on Nasdaq Helsinki Ltd. at the market price prevailing at the time of purchase. The shares were repurchased on the basis of the authorization given by the Annual General

Mandatory notification of trade

Sparebankstiftelsen SR-Bank, related party to board member Kjetil Skjæveland in SpareBank 1 SR-Bank ASA has on November 15 bought 2,557,510 shares in SpareBank 1 SR-Bank ASA at a price of NOK 118 per share. Following the transaction Kjetil Skjæveland owns 2,014 shares and Sparebankstiftelsen SR-Bank owns 74,976,815 shares, a total of 74,978,829 shares in SpareBank 1 SR-Bank ASA. This information is subject to the disclosure requirements according to MAR- article 19 and section 5-12 of the Norwegian Securities Trading Act.

ASSA ABLOY’s climate targets validated as science-based

ASSA ABLOY, the global leader in access solutions, has received validation by the Science Based Targets initiative (SBTi) for the company’s emission reduction targets.   In 2020, ASSA ABLOY launched ambitious sustainability goals to substantially reduce its greenhouse gas emissions across the entire value chain, including halving absolute emissions by 2030 and reaching net-zero no later than 2050. The SBTi has now ratified that ASSA ABLOY’s emission reduction targets are in line with the requirements to limit global warming to 1.5°C, which is consistent with the latest climate science

ABAX launches new policy to strengthen sustainable and responsible procurement

A substantial part of ABAX investments are spent through procurement, and by updating the policy, ABAX is adding extra quality control steps to ensure suppliers meet their minimum standards of GDPR and CSR. As part of the future digital transformation, the ABAX global purchasing and supply chain has been reviewed. Through a continuous improvement process in ABAX, the changes in the procurement policy are designed to increase quality and compliance and ensure alignment with the ABAX values: enthusiastic, customer-centric, innovative and sustainable. “The changes will streamline

Read original

Summons to the Extraordinary General Meeting of shareholders in Castellum AB (publ)

The shareholders of Castellum AB (publ), Reg. No. 556475-5550, are hereby summoned to the Extraordinary General Meeting to be held on Thursday, December 8, 2022.The Board of Directors has decided that the Extraordinary General Meeting is to be held only through advance voting (postal voting) in accordance with temporary legislation. This means that the Extraordinary General Meeting will be conducted without the physical presence of shareholders, representatives or external parties and that shareholders will only be able to exercise their voting rights by postal voting in advance of the

Ponsse once again one of the most reputable companies in Finland

Ponsse is the second most reputable company in Finland in 2022, behind the game development company Supercell and ahead of the lift and escalator company Kone.T-Media’s annual Reputation&Trust survey identifies the reputation of companies operating in Finland in the minds of Finnish people. Ponsse has been in the top three since 2017 – a total of six times during the reputation survey’s ten-year history. This year, Ponsse’s reputation was rated excellent, at 4.06. The other top three companies also received excellent scores: Supercell 4.11 and Kone 4.06. A total of 11,663 Finnish people

ASSA ABLOY today hosts its Capital Markets Day

Today, Wednesday 16 November, starting at 08:30 GMT (09:30 CET), ASSA ABLOY hosts its Capital Markets Day in London, UK, where Nico Delvaux, President & CEO and Erik Pieder, CFO, will provide an update on ASSA ABLOY’s strategy and direction. This will include an overview of strategic activities that ASSA ABLOY is working on to continue to grow the business profitably. The financial targets of an EBIT-margin of 16-17% and an annual sales growth of 10% over a business cycle are re-confirmed. No detailed outlook statement will be made. The CMD will also include an overview of Opening

Peab acquires civil engineering company in Larvik

Peab has signed a contract to acquire 90.4 percent of the shares in Arne Olav Lund A/S (AOL) based in Larvik. This acquisition reinforces Peab’s civil engineering business in Norway.AOL was founded by Arne Olav Lund and has operated as a construction contractor in the civil engineering industry since 1957. The company is domiciled in Larvik and in 2021 had net sales of around NOK 315 million. AOL works throughout eastern Norway with production and improvement of roads, water and waste water as well as with groundwork and landscaping. “Our goal is to become a local community builder in

LumenRadio intends to list its shares on the Nasdaq First North Growth Market

NOT FOR PUBLICATION, DISTRIBUTION, OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, OR OTHER COUNTRY IN WHICH SUCH PUBLICATION, DISTRIBUTION, OR MESSAGE WOULD BE ILLEGAL OR REQUIRE REGISTRATION OR OTHER MEASURES. PLEASE SEE IMPORTANT INFORMATION AT THE END OF THE PRESS RELEASE.LumenRadio AB (publ) (”LumenRadio” or ”the Company”), today announces its intention to list the Company’s shares on the Nasdaq First North Growth Market (the ”Listing”). In connection with the Listing, LumenRadio intends to carry out a new issue of shares of around SEK 50

Cereno Scientific publishes interim report for Q3 2022

The Board and Chief Executive Officer of Cereno Scientific AB here presents the interim report for Q3, 1 July – 30 September, 2022.Summary of the third quarter, July – September 2022 Cereno Scientific Group Third quarter (1 July – 30 September) · Net Sales were SEK 0 (0) · Result after financial items was SEK -7,248,364 (-3,356,309) · Earnings per share was SEK -0.07 (-0.05) before dilution and SEK -0.05 (-0.02) after dilution · The equity/assets ratio was 93.2% (89.9%) · Cash and bank balance was SEK 36,569,272 (28,583,402)   Parent company Third quarter (1

Repurchase of Outokumpu’s own shares

Outokumpu OyjStock exchange releaseNovember 16, 2022, at 9.00 am EETRepurchase of Outokumpu’s own shares On November 15, 2022, Outokumpu has completed repurchases its own shares as follows (ISIN FI0009002422): +-------+----------------+------------------------------------+----------------+|Trading|Number of shares|Weighted average price / share, EUR*|Total cost, EUR*||venue | | | |+-------+----------------+------------------------------------+----------------+|CEUX |66,173 |4.8024

Lantmännen’s Energy Sector wins ERP Project of the Year

The winners of the ERP Project of the Year 2021/2022 are Lantmännen Agroetanol and Lantmännen’s Energy Sector, together with the consultancy Elvenite, for the implementation of Infor M3.The award ERP Project of the Year has now been awarded for the sixth time, and is awarded to Lantmännen Agroetanol and the Energy division, together with the help of the consultancy Elvenite, for the implementation of Infor M3.  The award is presented by HerbertNathan & Co. “It is very gratifying to receive this award.  The key success factor within this project has always been the close collaboration –

Read original
There are no items matching the current filter
There are no more items matching the current filter
Back to top